Patients with greater clinical symptom severity had lower quality of life and higher functional impairment.
Reviews containing "wishlists" indicate that consumer needs are not adequately addressed by the apps that are currently available.
The findings show no significant difference among sertraline monotherapy, lithium monotherapy, or a combination of the 2 medications.
Serum concentration levels of several antidepressants were lower in cigarette smokers compared with nonsmokers.
No difference was observed in risk of overall cancer in patients with bipolar disorder who use lithium, compared with the general population.
For many off-label indications, the prescribed drug is often not supported by strong evidence for the respective indication.
Appropriate patient section for ketamine treatment should include diagnostic considerations and assessment of other medical, psychological, and social factors.
Differences in refusal rates for pharmacotherapy and psychotherapy were particularly evident for depressive disorders, panic disorder, and social anxiety disorder.
Reducing postpartum depression involves universal screening and appropriate referral and treatment by clinicians.
A better understanding of this complicated condition is key to helping patients reduce symptoms, maximize quality of life, and improve adaptive functioning skills.
Women with a good recovery after stroke and a moderate level of optimism had a 0.40‐fold reduction in the odds of developing new-onset poststroke depression.
Atypical antipsychotic adjunctive therapy and mood stabilizers may be a more effective treatment than mood stabilizer monotherapy.
Researchers measured vital status records to ascertain death from 16 site-specific malignancies.
Lithium has been the mainstay of treatment for decades, but several other classes of medication have recently been used with varying degrees of success.
The declining rates for lithium use are linked to the burden of side effects and toxicity associated with the drug.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
Some aspects of depression literacy were lower among patients with depression.
Comorbid panic disorder was linked to increased likelihood of side effects during treatment for depression.
About one-third of patients with MCI are also diagnosed with depression.
The Mood Zoom questionnaire rates anxiety, elation, sadness, anger, irritability, and energy on a 7-point scale.
The researchers found that the prevalence of anxiety was 21.3% and depression 27.2% in patients with HH.
The transition to standard time is likely to be associated with a negative psychological effect.
Cognitive reserve in bipolar patients gives a possible explanation for the differences seen among patients in their ability to perform in neurocognitive tests.
Patients taking memantine plus sertraline had significantly greater improvement and greater response rate.
Therapeutic drug monitoring and pharmacogenetic analyses may be useful in the optimization of clomipramine in nonresponders.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.
Researchers observe a cohort effect for earlier age at onset of bipolar disorder. Bipolar disorder is also more common in patients with a family history of unipolar depression and bipolar disorder.
Treatment initiated in the early stages of bipolar disorder is more effective than treatment in later stages.
Survey results revealed that only 28.7% of patients with depression receive any treatment.
The number needed to treat was 5.9 for sertraline vs placebo to prevent depression after a traumatic brain injury.